Survivin as a Therapeutic Target for the Treatment of Human Cancer

Qiang Wang1, Mark I Greene2

  • 1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Cancers
|May 11, 2024
PubMed

Insights

Survivin, a protein regulating cell death and mitosis, is overexpressed in cancers, driving tumor growth and drug resistance. Targeting survivin offers a promising strategy for developing novel cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Survivin, an inhibitor of apoptosis (IAP) protein, regulates apoptosis and mitotic progression.
  • It functions as a component of the chromosome passenger complex.
  • Emerging roles in mitochondrial function and autophagy are also proposed.

Purpose of the Study:

  • To review the multifaceted roles of survivin in cancer.
  • To discuss survivin's involvement in malignant transformation and drug resistance.
  • To summarize therapeutic strategies targeting survivin for cancer treatment.

Main Methods:

  • Literature review of survivin's functions and therapeutic targeting.
  • Analysis of survivin's role in apoptosis, mitosis, and cancer progression.
  • Evaluation of survivin-targeted drug development efforts.

Main Results:

  • Survivin overexpression is common in human cancers.
  • It correlates with chemotherapy resistance, recurrence, and poor patient survival.
  • Survivin's diverse functions contribute to malignant transformation.

Conclusions:

  • Survivin is a critical mediator of cancer development and progression.
  • Targeting survivin presents a viable therapeutic avenue for various cancers.
  • Further research into survivin-targeted therapies is warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358